TARGETED LIPOSOMES FOR DELIVERY OF PROTEIN-BASED DRUGS INTO THE CYTOPLASM OF TUMOR CELLS.

Autor: Mastrobattista, Enrico¹ (AUTHOR), Crommelin, Daan JA¹ (AUTHOR), Wilschut, Jan² (AUTHOR), Storm, Gert¹ (AUTHOR)

Publikováno v: Journal of Liposome Research. Feb2002, Vol. 12 Issue 1/2, p57-65. 9p.

Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells.

Autor: Mastrobattista, Enrico, Kapel, Robert HG, Eggenhuisen, Mark H, Roholl, Paul JM, Crommelin, Daan JA, Hennink, Wim E, Storm, Gert

Publikováno v: Cancer Gene Therapy; Jun2001, Vol. 8 Issue 6, p405, 9p

The regulator's perspective: How should new therapies and follow-on products for MS be clinically evaluated in the future?

Autor: Crommelin DJ; Department of Pharmaceutics, Pharmaceutical Sciences, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Sciences, Utrecht University, Utrecht, The Netherlands D.J.A.Crommelin@uu.nl., Broich K; President and Head of the Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), Bonn, Germany., Holloway C; European Regulatory Consultant, Chief Scientific Officer of ERA Consulting GmbH, Walsrode, Germany., Meesen B; Managing Director at Ismar Healthcare, Lier, Belgium., Lizrova Preiningerova J; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University, Prague, Czech Republic., Prugnaud JL; Expert Involved in the Development of Recommendations Related to Drug Registrations, Paris, France., Silva-Lima B; iMed.ULisboa, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.

Publikováno v: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2016 Aug; Vol. 22 (2 Suppl), pp. 47-59.